| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Akebia Therapeutics, Inc. (AKBA) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. AKBA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.46M | $4.02M | - | |
| CFO | 320.0K | $371.2K | - | |
| Dir | 160.9K | $186.7K | - | |
| Dir | 129.5K | $150.2K | - | |
| VP | 119.0K | $138.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2024 | Dahan Michel59 | SVP, Chief Operating Officer | Sell | 34,840 | $1.26 | $43,898.40 | -4.9% | -4.7% | +92.2% | |
| Feb 29, 2024 | Dahan Michel59 | SVP, Chief Operating Officer | Sell | 8,661 | $1.58 | $13,684.38 | -1.2% | -34.8% | +17.1% | |
| Feb 29, 2024 | Hadas Nicole R.60 | SVP, Chief Legal Officer | Sell | 5,974 | $1.58 | $9,438.92 | -0.9% | -34.8% | +17.1% | |
| Feb 29, 2024 | Butler John P.61 | CEO And President | Sell | 46,570 | $1.58 | $73,580.60 | -2.2% | -34.8% | +17.1% | |
| Feb 29, 2024 | Burke Steven Keith61 | SVP, Chief Medical Officer | Sell | 7,169 | $1.58 | $11,327.02 | -1.0% | -34.8% | +17.1% | |
| Feb 27, 2024 | Hadas Nicole R.60 | SVP, Chief Legal Officer | Sell | 7,411 | $1.52 | $11,264.72 | -1.1% | -34.8% | +9.8% | |
| Feb 27, 2024 | Dahan Michel59 | SVP, Chief Operating Officer | Sell | 10,744 | $1.52 | $16,330.88 | -1.5% | -34.8% | +9.8% | |
| Feb 27, 2024 | Burke Steven Keith61 | SVP, Chief Medical Officer | Sell | 8,367 | $1.52 | $12,717.84 | -1.2% | -34.8% | +9.8% | |
| Feb 27, 2024 | Butler John P.61 | CEO And President | Sell | 37,733 | $1.52 | $57,354.16 | -1.8% | -34.8% | +9.8% | |
| Feb 1, 2024 | Butler John P.61 | CEO And President | Sell | 46,489 | $1.68 | $78,101.52 | -2.1% | -27.5% | +31.0% |